fig 1

Figure 1. Time of maximum lesion count (Lmax) and clinical appearance of lesions during treatment with imiquimod 3.75%. (A) Total reduction in lesion count including lesions that were subclinical at baseline (Lmax minus final count). (B) Change in lesion count according to the conventional measure of baseline count minus final count. EOS, end of study